Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP757871.RA4mKgp2uHRE9W_49PxS5umU_tVaL___ifclpObUU7mgw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP757871.RA4mKgp2uHRE9W_49PxS5umU_tVaL___ifclpObUU7mgw130_assertion type Assertion NP757871.RA4mKgp2uHRE9W_49PxS5umU_tVaL___ifclpObUU7mgw130_head.
- NP757871.RA4mKgp2uHRE9W_49PxS5umU_tVaL___ifclpObUU7mgw130_assertion description "[LRH-1 mRNA was present at low level in normal ovary and serous cystadenocarcinoma, but was elevated approximately 30-fold in GCT, and 8-fold in mucinous cystadenocarcinoma, compared to normal ovary.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP757871.RA4mKgp2uHRE9W_49PxS5umU_tVaL___ifclpObUU7mgw130_provenance.
- NP757871.RA4mKgp2uHRE9W_49PxS5umU_tVaL___ifclpObUU7mgw130_assertion evidence source_evidence_literature NP757871.RA4mKgp2uHRE9W_49PxS5umU_tVaL___ifclpObUU7mgw130_provenance.
- NP757871.RA4mKgp2uHRE9W_49PxS5umU_tVaL___ifclpObUU7mgw130_assertion SIO_000772 23537609 NP757871.RA4mKgp2uHRE9W_49PxS5umU_tVaL___ifclpObUU7mgw130_provenance.
- NP757871.RA4mKgp2uHRE9W_49PxS5umU_tVaL___ifclpObUU7mgw130_assertion wasDerivedFrom befree-20140225 NP757871.RA4mKgp2uHRE9W_49PxS5umU_tVaL___ifclpObUU7mgw130_provenance.
- NP757871.RA4mKgp2uHRE9W_49PxS5umU_tVaL___ifclpObUU7mgw130_assertion wasGeneratedBy ECO_0000203 NP757871.RA4mKgp2uHRE9W_49PxS5umU_tVaL___ifclpObUU7mgw130_provenance.